1887

Abstract

The association of hepatitis B virus (HBV) infection with hepatocellular carcinoma (HCC) is well established. Insertional mutagenesis, trans-activation by truncated X or preS2/S regions and activation of growth regulatory genes or oncogenes have all been suggested as possible mechanisms for this carcinogenesis. However, no consensus regarding the mechanism or region of the HBV genome involved has been established. Of the 36 HCC tissues analysed for the presence and extent of the HBV genome, using multiple overlapping PCR, 22 (61%) were found to be positive. Twenty of these showed the presence of a fragment (nucleotides 636 to 746) that covered part of the surface antigen gene. The recognized trans-activators, X and preS2/S, were present in only seven (31·8%) and 12 (54·5%) cases, respectively. In two cases the entire viral genome was detected. The trans-activation potential of the cloned S fragment (nucleotides 426 to 851) covering the frequently detected fragment (nucleotides 636 to 746) was investigated in co-transfection experiments. This fragment was able to trans-activate the HBV enhancer-X promoter target. To define the specificity of the trans-activation and the sequences involved, frameshift and deletion mutants of this fragment were constructed and analysed. The transactivation activity was lost in the frameshift mutants. The deletion mutants that retained nucleotide sequences 436 to 679 showed trans-activation activity whereas the other ones (nucleotide sequences 436 to 611) did not show any activity. It is suggested that the frequently detected HBV genome fragment belonging to the S gene frame has a trans-activation potential. This may explain the mechanism for pathogenicity of HBV-associated HCC.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-2-327
1994-02-01
2022-01-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/2/JV0750020327.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-2-327&mimeType=html&fmt=ahah

References

  1. Baginski I., Ferrier A., Watson R., Mack D. 1990; Detection of hepatitis B virus. In PCR protocols: A Guide to Methods and Applications pp. 348–355 Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. Edited by New York: Academic Press;
    [Google Scholar]
  2. Beasley R. P. 1982; Hepatitis B virus as the etiologic agent in hepatocellular carcinoma. Epidemiologic considerations. Hepatology 2:21–26
    [Google Scholar]
  3. Brechot C., Hadchouel M., Scotto J., Degas F., Potet F., Vyas G. N., Tiollais P. 1981; State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen positive and negative liver disease. Proceedings of the National Academy of Sciences U.S.A: 783906–3910
    [Google Scholar]
  4. Chen J. Y., Harrison T. J., Lee C. S., Chen D. S., Zuckerman A. J. 1988; Detection of hepatitis B virus DNA in hepatocellular carcinoma: analysis by hybridisation with subgenomic DNA fragments. Hepatology 8:518–523
    [Google Scholar]
  5. Chisari F. V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H. A., Sell S., Pinkert C. A., Brinster R. L., Palmiter R. D. 1989; Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145–1156
    [Google Scholar]
  6. Dejan A., Bougueleret L., Grzeschik K. H., Tiollais P. 1986; Hepatitis B virus DNA integration in a sequence homologous to y-erb A and steroid receptor genes in a hepatocellular carcinoma. Nature; London: 32270–72
    [Google Scholar]
  7. De The H., Marchio A., Tiollais P., Dejean A. 1987; A novel steroid thyroid hormone receptor-related gene is appropriately expressed in human hepatocellular carcinoma. Nature; London: 330667–670
    [Google Scholar]
  8. De Wet J., Wood K., Deluca M., Helinski D., Subramani S. 1987; Firefly luciferase gene: structure and expression in mammalian cells. Molecular and Cellular Biology 7:725–737
    [Google Scholar]
  9. Feinberg A. P., Vogelstein B. 1985; A technique for radiolabelling DNA restriction endonuclease fragments to a high specific activity. Analytical Biochemistry 132:6–13
    [Google Scholar]
  10. Fourel G., Trepo C., Bougueleret L., Henglein B., Ponzetto A., Tiollais P., Buendia M. A. 1990; Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature; London: 347294–298
    [Google Scholar]
  11. Fu X. X., Su C. Y., Lee Y., Hintz R., Biempica L., Snyder R., Rogler C. E. 1988; Insulin-like growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. Journal of Virology 62:3422–3430.
    [Google Scholar]
  12. Gorman C. M., Padmanabhan R., Howard B. H. 1983; High efficiency DNA-mediated transformation of primate cells. Science 221:551–553
    [Google Scholar]
  13. Green S., Issemann I., Sheer E. 1988; A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Research 16:369
    [Google Scholar]
  14. Heldin C. E., Westermark B. 1984; Growth factors: mechanism of action and relation to oncogenes. Cell 37:9–20
    [Google Scholar]
  15. Himeno Y., Fukuda Y., Hatanaka M., Imura W. 1988; Expression of oncogenes in human liver disease. Liver 8:208–212
    [Google Scholar]
  16. Kekule A. S., Lauer U., Meyer M., Caselman W. H., Hofschneider P. H., Koshy R. 1990; The pre S2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature; London: 343457–461
    [Google Scholar]
  17. Kostich N. D., Ingham C. D. 1977; Detection of hepatitis B surface antigen by means of orcein staining in liver. American Journal of Clinical Pathology 67:20–30
    [Google Scholar]
  18. Kwok S., Higuchi R. 1989; Avoiding false positives with PCR. Nature; London: 339237–238
    [Google Scholar]
  19. Larzul D., Guigue F., Sninsky J. J., Mack D. H., Brechot C., Guedson J. L. 1988; Detection of hepatitis B virus sequences in serum using in vitro enzymatic amplification. Journal of Virological Methods 20:227–237
    [Google Scholar]
  20. Meyer M., Caselman W. H., Schlutbr V., Schreck R., Hofschneider P. H., Baeuerle P. A. 1992; Hepatitis B virus transactivator MHBst: activation of NFkB, selective inhibition by antioxidants and integral membrane localisation. EMBO Journal 11:2991–3001
    [Google Scholar]
  21. Moroy T., Marchio A., Etiemble J., Trepo C., Tiollais P., Buendia M. A. 1986; Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature; London: 324276–279
    [Google Scholar]
  22. Nakamura T., Torino T., Nagaya T., Matsubara K. 1988; Microdeletion associated with integration process of hepatitis B virus DNA. Nucleic Acids Research 16:4865–4873
    [Google Scholar]
  23. Panda S. K., Ramesh R., Rao K. V. S., Gupta A., Zuckerman A. J., Nayak N. C. 1991; Comparative evaluation of yeast derived recombinant and plasma derived hepatitis B virus vaccine in prevention of perinatally transmitted infection in north India. Journal of Medical Virology 35:297–302
    [Google Scholar]
  24. Paterlini P., Gerken G., Nakajima E., Terre S., D’Errico A., Grigioni W., Nalpas B., Franco D., Wands J., Kew M., Pisi E., Tiollais P., Brechot C. 1990; Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancer from patients negative for hepatitis B surface antigen. New England Journal of Medicine 323:80–85
    [Google Scholar]
  25. Rogler C. E., Sherman M., Su C. Y., Shafritz D. A., Summers J., Shows T. B., Henderson A., Kew M. 1985; Deletion of chromosome lip associated with a hepatitis B integration site in hepatocellular carcinoma. Science 250:319–322
    [Google Scholar]
  26. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual,, 2nd edn.. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  27. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Science U.S.A: 745463–5467
    [Google Scholar]
  28. Shafritz D. A., Kew M. C. 1981; Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinoma. Hepatology 1:1–8
    [Google Scholar]
  29. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
  30. Szmuness W. 1978; Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Progress in Medical Virology 24:40–69
    [Google Scholar]
  31. Takada S., Koike K. 1990; Transactivation function of a 3′ truncated X gene cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proceedings of the National Academy of Sciences U.S.A: 875628–5632
    [Google Scholar]
  32. Takada S., Gotoh Y., Hayashi S., Yoshida M., Koike K. 1990; Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissue. Journal of Virology 64:822–828
    [Google Scholar]
  33. Trujillo M. A., Letovsky J., Maguire H. F., Lopez-Cabrera M., Siddiqui A. 1991; Functional analysis of a liver specific enhancer of the hepatitis B virus. Proceedings of the National Academy of Sciences U.S.A: 883797–3801
    [Google Scholar]
  34. Wang J., Cheniverse X., Henglein B., Brechot C. 1990; Hepatitis B virus integration in a cyclin gene in a hepatocellular carcinoma. Nature; London: 343555–557
    [Google Scholar]
  35. Zhou X. D., Tang Z. Y., Yu Y. Q., Yang B. H., Lin Z. Y., Lu J. Z., Tang C. L. 1989; Long-term survivors after resecting from primary liver cancer. Clinical analysis of 19 patients surviving more than ten years. Cancer 63:2201–2206
    [Google Scholar]
  36. Ziemer M., Garcia P., Shaul Y., Rutter W. J. 1985; Sequences of hepatitis B virus DNA incorporated into the genome of a human hepatoma cell line. Journal of Virology 53:885–892
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-2-327
Loading
/content/journal/jgv/10.1099/0022-1317-75-2-327
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error